Psoriasis Treatment Ctr-S FL Hollywood, FL - 33028

Psoriasis Treatment Ctr-S FL is categorized under Doctors in Hollywood, FL and active since 2010.

Psoriasis Treatment Ctr-S FL was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Robert A Snyder at the company’s single location by writing to 603 North Flamingo Road # 350, Hollywood, Florida FL 33028 or by phoning (954) 435-1122. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Psoriasis Treatment Ctr-S FL
Contact Person: Robert A Snyder
Address: 603 North Flamingo Road # 350, Hollywood, Florida 33028
Phone Number: (954) 435-1122
Website Address: psoriasistreatmentsfl.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Psoriasis Treatment Ctr-S FL was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Robert A Snyder for inquiries that concern Psoriasis Treatment Ctr-S FL by calling the company number (954) 435-1122, as your correspondence is most welcome. Additionally, the physical location of the single location of Psoriasis Treatment Ctr-S FL can be found at the coordinates 26.01255,-80.312091 as well as the street address 603 North Flamingo Road # 350 in Hollywood, Florida 33028.

For its online presence, you may visit Psoriasis Treatment Ctr-S FL’s website at psoriasistreatmentsfl.com and engage with its social media outlets through on Twitter and on Facebook.